NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer-Reference-Cited by-同舟云学术

NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

Published:2023-03 Issue:3 Volume:35 Page:487-503.e7
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Weiss-Sadan Tommy,Ge Maolin,Hayashi Makiko,Gohar Magdy,Yao Cong-Hui,de Groot Adriaan,Harry Stefan,Carlin Alexander,Fischer Hannah,Shi Lei,Wei Ting-Yu,Adelmann Charles H.,Wolf Konstantin,Vornbäumen Tristan,Dürr Benedikt R.,Takahashi Mariko,Richter Marianne,Zhang Junbing,Yang Tzu-Yi,Vijay Vindhya,Fisher David E.,Hata Aaron N.,Haigis Marcia C.,Mostoslavsky Raul,Bardeesy Nabeel,Papagiannakopoulos Thales,Bar-Peled Liron

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference111 articles.

1. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment;Kerk;Nat. Rev. Cancer,2021

2. Cancer metabolism: looking forward;Martínez-Reyes;Nat. Rev. Cancer,2021

3. Cancer cell metabolism: one hallmark, many faces;Cantor;Cancer Discov.,2012

4. Understanding the intersections between metabolism and cancer biology;Vander Heiden;Cell,2017

5. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism;Elia;Nat. Metab.,2021

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise mitigates reductive stress-induced cardiac remodeling in mice;Redox Biology;2024-09

2. Cepharanthine triggers ferroptosis through inhibition of NRF2 for robust ER stress against lung cancer;European Journal of Pharmacology;2024-09

3. TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma;2024-08-10

4. Innovating cancer drug discovery with refined phenotypic screens;Trends in Pharmacological Sciences;2024-08

5. Hernandezine acts as a CDK4 suppressor inhibiting tumor growth by the CDK4/PKM2/NRF2 axis in colon cancer;Phytomedicine;2024-08